Evidence map›Paper›PMID 42344915›Full record

ReviewFrontiers in immunology2026

Piezo1 in immune cells: from mechanosensation to immunoregulation.

Yuling Liang, Qiuxia Chen, Shuqiao Zhang, Ting Xiang, Juan Du, Shijun Zhang

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuling LiangDepartment of Traditional Chinese Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Qiuxia ChenDepartment of Traditional Chinese Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Shuqiao ZhangThe First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Ting XiangDepartment of Traditional Chinese Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Juan DuNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Shijun ZhangDepartment of Traditional Chinese Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The immune system is central to host defense against pathogens and the maintenance of organismal homeostasis. Immune cells often reside in or migrate through tissue microenvironments characterized by significant mechanical activity, where they are continuously subjected to diverse mechanical stimuli. Despite the ubiquity of mechanical signals in such contexts, the precise regulatory mechanisms by which these signals control immune cell function in a context-dependent manner remain incompletely understood. Main body: In recent years, the mechanosensitive ion channel Piezo1 has emerged as a core component of cellular mechanical sensing system, attracting considerable attention in immunology. This review integrates the latest research advances to systematically analyze the role of Piezo1 in both innate and adaptive immune cells. We discuss how Piezo1 is widely involved in key immune processes, including cell activation, differentiation, and functional regulation, and highlight the context-dependent nature of Piezo1 signaling, which can drive divergent immune outcomes depending on cellular lineage and pathological microenvironment. Conclusions: By synthesizing the current evidence, this review provides a theoretical foundation for understanding mechanical signaling in immunity. Crucially, this underscores that the functional duality and context-dependency of Piezo1 present both opportunities and challenges for drug targeting, offering insights for the development of precision immunotherapies that account for specific pathological settings.

Indexed as

Ion ChannelsMechanotransduction, CellularAdaptive ImmunityAnimalsHumansImmunity, InnateImmunomodulationSignal TransductionIon ChannelsPIEZO1 protein, humancancer immunityimmune cellsimmunotherapymechanoimmunologyPiezo1

Identifiers

PMID42344915
PMCPMC13287921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.